Eton Pharmaceuticals, Inc. (ETON)
55.36
+3.38
(+6.50%)
USD |
NASDAQ |
Oct 02, 16:00
55.37
+0.01
(+0.02%)
After-Hours: 20:00
Eton Pharmaceuticals Market Cap : 1.566B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.566B |
| October 01, 2026 | 1.471B |
| September 30, 2026 | 1.457B |
| September 29, 2026 | 1.674B |
| September 28, 2026 | 1.674B |
| September 25, 2026 | 1.632B |
| September 24, 2026 | 1.683B |
| September 23, 2026 | 1.573B |
| September 22, 2026 | 1.615B |
| September 21, 2026 | 1.565B |
| September 18, 2026 | 1.570B |
| September 17, 2026 | 1.615B |
| September 16, 2026 | 1.594B |
| September 15, 2026 | 1.554B |
| September 14, 2026 | 1.630B |
| September 11, 2026 | 1.615B |
| September 10, 2026 | 1.637B |
| September 09, 2026 | 1.664B |
| September 08, 2026 | 1.679B |
| September 04, 2026 | 1.654B |
| September 03, 2026 | 1.695B |
| September 02, 2026 | 1.753B |
| September 01, 2026 | 1.710B |
| August 31, 2026 | 1.710B |
| August 28, 2026 | 1.691B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.773B |
| August 26, 2026 | 1.772B |
| August 25, 2026 | 1.784B |
| August 24, 2026 | 1.823B |
| August 21, 2026 | 1.796B |
| August 20, 2026 | 1.695B |
| August 19, 2026 | 1.739B |
| August 18, 2026 | 1.794B |
| August 17, 2026 | 1.746B |
| August 14, 2026 | 1.665B |
| August 13, 2026 | 1.154B |
| August 12, 2026 | 1.176B |
| August 11, 2026 | 1.190B |
| August 10, 2026 | 1.195B |
| August 07, 2026 | 1.220B |
| August 06, 2026 | 1.263B |
| August 05, 2026 | 1.258B |
| August 04, 2026 | 1.254B |
| August 03, 2026 | 1.235B |
| July 31, 2026 | 1.270B |
| July 30, 2026 | 1.341B |
| July 29, 2026 | 1.317B |
| July 28, 2026 | 1.277B |
| July 27, 2026 | 1.158B |
| July 24, 2026 | 1.165B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 158.43B |
| Elite Pharmaceuticals, Inc. | 246.29M |
| Daré Bioscience, Inc. | 12.78M |
| Liquidia Corp. | 2.552B |
| ANI Pharmaceuticals, Inc. | 1.658B |
Market Cap Related Metrics
| PE Ratio | 146.34 |
| PS Ratio | 16.05 |
| Price to Book Value | 33.62 |
| Price | 55.36 |
| Earnings Yield | 0.68% |
| Operating PE Ratio | 102.69 |
| Normalized PE Ratio | 144.43 |